1. Home
  2. ZETA vs HAE Comparison

ZETA vs HAE Comparison

Compare ZETA & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zeta Global Holdings Corp.

ZETA

Zeta Global Holdings Corp.

HOLD

Current Price

$16.98

Market Cap

4.6B

Sector

Technology

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$57.68

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZETA
HAE
Founded
2007
1971
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
3.9B
IPO Year
2021
1991

Fundamental Metrics

Financial Performance
Metric
ZETA
HAE
Price
$16.98
$57.68
Analyst Decision
Strong Buy
Buy
Analyst Count
12
9
Target Price
$27.25
$86.00
AVG Volume (30 Days)
9.6M
1.0M
Earning Date
02-24-2026
02-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
43.84
EPS
N/A
3.65
Revenue
$1,224,703,000.00
$1,318,275,000.00
Revenue This Year
$30.75
N/A
Revenue Next Year
$33.16
$5.86
P/E Ratio
N/A
$16.25
Revenue Growth
35.87
N/A
52 Week Low
$10.69
$47.32
52 Week High
$26.60
$87.32

Technical Indicators

Market Signals
Indicator
ZETA
HAE
Relative Strength Index (RSI) 36.39 16.29
Support Level $15.86 $64.75
Resistance Level $22.34 $67.63
Average True Range (ATR) 1.08 2.44
MACD -0.51 -0.89
Stochastic Oscillator 17.05 3.90

Price Performance

Historical Comparison
ZETA
HAE

About ZETA Zeta Global Holdings Corp.

Zeta Global Holdings Corp is an omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software. It serves enterprise customers across multiple industries, including financial services, insurance, telecommunications, automotive, travel and hospitality, and retail. Its Zeta Marketing Platform, or ZMP, is an omnichannel marketing platform with identity data at its core. The ZMP can analyze billions of structured and unstructured data points to predict consumer intent by leveraging sophisticated machine learning algorithms and the industry's opted-in data set for omnichannel marketing.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: